ArticleBMC women's health2026
Prevalence and associated factors of sexual dysfunction in female patients with immune thrombocytopenia: a longitudinal follow-up study.
Article in BMC women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSexual health is an important part of life; however, it has long been overlooked in patients with immune thrombocytopenia (ITP), primarily due to concerns regarding low platelet counts and bleeding risk.
objectiveThis study aimed to assess the prevalence of sexual dysfunction in female patients with ITP and to analyze the factors contributing to this condition.
methodsThis was a single-center longitudinal follow-up study that enrolled female patients aged 18 to 65 years with newly diagnosed ITP between January 2021 and December 2023. Sexual function was assessed using the Female Sexual Function Index (FSFI) at baseline (within 48 h of admission) and at the 6- and 12-month follow-up. Demographic and clinical data of patients were additionally collected, and their fatigue burden, anxiety levels, and quality of life were assessed. Logistic regression analysis was employed to identify risk factors.
resultsA total of 146 patients were enrolled in this study. At baseline, sexual dysfunction was identified in 36.30% of female patients with ITP. At 6-month and 12-month follow-ups, the proportion of patients with sexual dysfunction was 41.84% and 54.07%, respectively. Compared with patients without corticosteroid dependence (49.54%), those on two or fewer medications (44.83%), and those with only isolated cutaneous bleeding (51.90%), the prevalence of sexual dysfunction was significantly higher in patients with corticosteroid dependence (73.08%, P = 0.047), those receiving more than two medications (70.83%, P = 0.004), and those with wet or internal bleeding (70%, P = 0.007). Spearman correlation analysis revealed that as the follow-up duration increased, the correlation between fatigue and the FSFI score weakened, whereas the correlations between anxiety, quality of life, and the FSFI score strengthened. A platelet count of <30 × 109/L (OR = 4.996; P = 0.039), wet or internal bleeding (OR = 3.744; P = 0.016), and the use of more than two medications (OR = 2.861; P = 0.031) were independent risk factors for sexual dysfunction in patients with ITP at the 12-month follow-up.
conclusionsITP can adversely affect female patients’ sexual function. Based on the results of logistic regression analysis, rational and individualized intervention plans should be developed to improve sexual function in female patients with ITP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.